🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are urged to message these profiles directly for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share comparison photos, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

However, physicians and chemists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to individuals administering products of unknown origin.

Some experts said the popularity for the experimental drug could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Content Removal

Based on the social media company, the platform has taken down problematic material and banned associated hashtags and search suggestions. The organization said it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered communities with up to nine thousand members selling retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of members, filled with photos of slimming results, positive reviews and step-by-step guides for mixing or administering at home.

After minutes of entering one community, a vendor shared contact information, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.

Item Details and Costs

Inside these communities, posts display black plastic packages with postal service labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram said it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they cannot confirm. Although the science behind retatrutide is sound, these digital versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her staff has previously encountered patients injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose patients to possibly serious health risks”.